$LOAN
Manhattan Bridge Capital Inc

2015 Q4 Form 10-Q Financial Statement

#000114420415061351 Filed on October 29, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q4
Revenue $1.150M $1.032M $900.0K
YoY Change 27.78% 34.74% 52.54%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $340.0K $230.0K $320.0K
YoY Change 6.25% 15.0% 10.34%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.00K $0.00
YoY Change
% of Gross Profit
Operating Expenses $340.0K $230.0K $320.0K
YoY Change 6.25% 9.52% 14.29%
Operating Profit $641.0K
YoY Change 53.41%
Interest Expense -$200.0K -$160.0K -$180.0K
YoY Change 11.11% 14.29% 50.0%
% of Operating Profit -24.96%
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income $590.0K $641.0K $400.0K
YoY Change 47.5% 50.92% 166.67%
Income Tax $0.00 $2.005K $0.00
% Of Pretax Income 0.0% 0.31% 0.0%
Net Earnings $590.0K $639.0K $400.0K
YoY Change 47.5% 48.95% 566.67%
Net Earnings / Revenue 51.3% 61.94% 44.44%
Basic Earnings Per Share $0.09
Diluted Earnings Per Share $81.49K $0.09 $65.90K
COMMON SHARES
Basic Shares Outstanding 7.231M shares 7.223M shares 6.060M shares
Diluted Shares Outstanding 7.263M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $110.0K $60.00K $50.00K
YoY Change 120.0% 0.0% -95.1%
Cash & Equivalents $106.8K $61.14K $47.68K
Short-Term Investments
Other Short-Term Assets $32.87K $54.37K $27.00K
YoY Change 21.74% 5.13% 45.6%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.72M $16.07M $19.43M
YoY Change 6.66% -11.05% 63.13%
LONG-TERM ASSETS
Property, Plant & Equipment $8.771K $17.64K $19.09K
YoY Change -54.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $50.00K $50.00K $70.00K
YoY Change -28.57% -76.19% -66.67%
Other Assets $170.0K $120.0K $0.00
YoY Change 1100.0%
Total Long-Term Assets $10.94M $13.70M $5.017M
YoY Change 117.94% 151.04% 19.03%
TOTAL ASSETS
Total Short-Term Assets $20.72M $16.07M $19.43M
Total Long-Term Assets $10.94M $13.70M $5.017M
Total Assets $31.66M $29.77M $24.44M
YoY Change 29.5% 26.55% 51.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K $90.00K $160.0K
YoY Change -37.5% 125.0% 166.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.096M $1.096M $2.469M
YoY Change -55.63% -52.76% 87.16%
Long-Term Debt Due $11.82M $10.10M $7.700M
YoY Change 53.51% 44.29% 43.93%
Total Short-Term Liabilities $13.91M $11.53M $10.58M
YoY Change 31.53% 19.59% 46.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $13.91M $11.53M $10.58M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $13.91M $11.53M $10.58M
YoY Change 31.51% 19.61% 46.33%
SHAREHOLDERS EQUITY
Retained Earnings -$395.7K $113.3K
YoY Change -449.11% -123.24%
Common Stock $18.51M $14.12M
YoY Change 31.05% 44.85%
Preferred Stock
YoY Change
Treasury Stock (at cost) $369.3K $369.3K
YoY Change 0.0% 0.0%
Treasury Stock Shares 177.0K shares 177.0K shares 177.0K shares
Shareholders Equity $17.74M $18.24M $13.87M
YoY Change
Total Liabilities & Shareholders Equity $31.66M $29.77M $24.44M
YoY Change 29.5% 26.53% 51.6%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q4
OPERATING ACTIVITIES
Net Income $590.0K $639.0K $400.0K
YoY Change 47.5% 48.95% 566.67%
Depreciation, Depletion And Amortization $10.00K $0.00
YoY Change
Cash From Operating Activities $620.0K $740.0K $500.0K
YoY Change 24.0% 80.49% 108.33%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $0.00 -$20.00K
YoY Change -50.0%
Acquisitions
YoY Change
Other Investing Activities -$1.760M -$3.240M -$880.0K
YoY Change 100.0% -46.71% -223.94%
Cash From Investing Activities -$1.760M -$3.240M -$900.0K
YoY Change 95.56% -46.71% -226.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.190M 2.520M 400.0K
YoY Change 197.5% -54.92% 3900.0%
NET CHANGE
Cash From Operating Activities 620.0K 740.0K 500.0K
Cash From Investing Activities -1.760M -3.240M -900.0K
Cash From Financing Activities 1.190M 2.520M 400.0K
Net Change In Cash 50.00K 20.00K -0.00000000005821
YoY Change -85899345920001900.0% -125.0% -100.0%
FREE CASH FLOW
Cash From Operating Activities $620.0K $740.0K $500.0K
Capital Expenditures -$10.00K $0.00 -$20.00K
Free Cash Flow $630.0K $740.0K $520.0K
YoY Change 21.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
MANHATTAN BRIDGE CAPITAL, INC
dei Entity Central Index Key
EntityCentralIndexKey
0001080340
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
163622 USD
CY2015Q3 loan Deferred Origination Fees
DeferredOriginationFees
249135 USD
CY2014Q4 loan Deferred Origination Fees
DeferredOriginationFees
244776 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11532429 USD
dei Trading Symbol
TradingSymbol
LOAN
CY2014Q3 loan Interest Income From Loans
InterestIncomeFromLoans
631640 USD
CY2015Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
1095620 USD
CY2015Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
10098083 USD
CY2014Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
7700000 USD
CY2015Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
89591 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10577863 USD
CY2014Q3 loan Origination Fees
OriginationFees
134080 USD
CY2014Q3 us-gaap Revenues
Revenues
765720 USD
CY2015Q3 us-gaap Revenues
Revenues
1031706 USD
CY2014Q3 loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
144392 USD
CY2015Q3 loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
159875 USD
CY2015Q3 loan Referral Fees
ReferralFees
948 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
202822 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
229873 USD
CY2014Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
347879 USD
CY2015Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
390696 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
417841 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
641010 USD
CY2014Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6887 USD
CY2015Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47676 USD
CY2015Q3 loan Short Term Loans Receivable
ShortTermLoansReceivable
15633990 USD
CY2014Q4 loan Short Term Loans Receivable
ShortTermLoansReceivable
19138426 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61144 USD
CY2015Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
322582 USD
CY2014Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
213766 USD
CY2015Q3 us-gaap Other Assets Current
OtherAssetsCurrent
54370 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
26995 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
16072086 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
19426863 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17636 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19088 USD
CY2015Q3 us-gaap Security Deposit
SecurityDeposit
6816 USD
CY2014Q4 us-gaap Security Deposit
SecurityDeposit
6816 USD
CY2015Q3 us-gaap Cost Method Investments
CostMethodInvestments
50000 USD
CY2014Q4 us-gaap Cost Method Investments
CostMethodInvestments
65000 USD
CY2015Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
116399 USD
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
32500 USD
CY2015Q3 us-gaap Assets
Assets
29772987 USD
CY2014Q4 us-gaap Assets
Assets
24444317 USD
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7231489 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5487494 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7223043 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2015Q3 loan Interest Income From Loans
InterestIncomeFromLoans
871250 USD
CY2015Q3 loan Origination Fees
OriginationFees
160456 USD
CY2014Q3 loan Referral Fees
ReferralFees
665 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
424728 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
641010 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4291 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2005 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
429019 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
639005 USD
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5526798 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7263017 shares
loan Interest Income From Loans
InterestIncomeFromLoans
2392329 USD
loan Interest Income From Loans
InterestIncomeFromLoans
1657076 USD
loan Origination Fees
OriginationFees
463092 USD
loan Origination Fees
OriginationFees
347637 USD
us-gaap Revenues
Revenues
2855421 USD
us-gaap Revenues
Revenues
2004713 USD
loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
493652 USD
loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
383721 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1193376 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
939401 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1662045 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1065312 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
20661 USD
CY2015Q3 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
0 USD
CY2014Q3 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
0 USD
us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
15000 USD
us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1647045 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1085973 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2005 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27709 USD
us-gaap Net Income Loss
NetIncomeLoss
1645040 USD
us-gaap Net Income Loss
NetIncomeLoss
1058264 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6597987 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4680340 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6637755 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4727966 shares
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
27501 USD
us-gaap Share Based Compensation
ShareBasedCompensation
17799 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10248 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
21850 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
108815 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
33357 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
27377 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-14409 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-74031 USD
loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
-149550 USD
loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
-4360 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-373219 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
782778 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1496852 USD
loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
18827000 USD
loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
15346500 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
10518616 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
10234936 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-8308384 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5115038 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
429329 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1551221 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
111400 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6564666 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3631654 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-960940 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
13468 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1021023 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60083 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
415928 USD
us-gaap Interest Paid
InterestPaid
383721 USD
us-gaap Depreciation
Depreciation
0 USD
us-gaap Depreciation
Depreciation
4926 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3474 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4237199 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4288765 USD
CY2015Q3 loan Jointly Funded Loans Total
JointlyFundedLoansTotal
2270000 USD
CY2015Q3 loan Jointly Funded Loans
JointlyFundedLoans
1447500 USD
CY2013Q4 us-gaap Cost Method Investments
CostMethodInvestments
65000 USD
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
39304 shares
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
39974 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
39768 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
47626 shares
CY2015Q3 loan Share Based Compensation Expense
ShareBasedCompensationExpense
3416 USD
loan Share Based Compensation Expense
ShareBasedCompensationExpense
10248 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0959 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.595 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0171 pure
CY2014Q3 loan Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
87719 shares
CY2014Q3 loan Warrants Exercise Price
WarrantsExercisePrice
3.5625
CY2014Q3 loan Warrants Expiry Date
WarrantsExpiryDate
2019-07-28
CY2014Q3 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
42224 USD
CY2015Q2 loan Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
50750 shares
CY2015Q2 loan Warrants Exercise Price
WarrantsExercisePrice
5.4875
CY2015Q2 loan Warrants Expiry Date
WarrantsExpiryDate
2020-05-22
CY2015Q2 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
54928 USD
CY2015Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.12 pure
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1024238 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2650000 USD
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7401489 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6260689 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7224489 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6083689 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
177000 shares
CY2015Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
177000 shares
CY2014Q3 loan Share Based Compensation Expense
ShareBasedCompensationExpense
10967 USD
loan Share Based Compensation Expense
ShareBasedCompensationExpense
17799 USD
loan Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights For Employee And Nonemployee Directors
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsForEmployeeAndNonemployeeDirectors
The options may vest over a period not to exceed ten years. Stock options under our stock option plan may be awarded to officers, key-employees, consultants and non-employee directors of the Company. Under our stock option plan, generally, each non-employee director of the Company is granted an option for 7,000 common shares upon first taking office, and through and including the fiscal year ended December 31, 2014, an annual option grant for an additional 7,000 common shares for each additional year in office.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2015Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount Commercial
LoansAndLeasesReceivableGrossCarryingAmountCommercial
29144040 USD
CY2014Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount Commercial
LoansAndLeasesReceivableGrossCarryingAmountCommercial
23003335 USD
loan Net Proceeds From Issuance Initial Public Offering
NetProceedsFromIssuanceInitialPublicOffering
4240000 USD
loan Gross Proceeds From Issuance Initial Public Offering
GrossProceedsFromIssuanceInitialPublicOffering
4920000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1000000 USD

Files In Submission

Name View Source Status
0001144204-15-061351-index-headers.html Edgar Link pending
0001144204-15-061351-index.html Edgar Link pending
0001144204-15-061351.txt Edgar Link pending
0001144204-15-061351-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
loan-20150930.xml Edgar Link completed
loan-20150930.xsd Edgar Link pending
loan-20150930_cal.xml Edgar Link unprocessable
loan-20150930_def.xml Edgar Link unprocessable
loan-20150930_lab.xml Edgar Link unprocessable
loan-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v422413_10q.htm Edgar Link pending
v422413_ex31-1.htm Edgar Link pending
v422413_ex31-2.htm Edgar Link pending
v422413_ex32-1.htm Edgar Link pending
v422413_ex32-2.htm Edgar Link pending